Leadership Overview
B. Braun has 10 executives leading key functions including financial strategy, information technology, administrative oversight, and global operations.
Committed to advancing medical technology, B. Braun delivers innovative solutions for infusion therapy, surgical instruments, and dialysis to improve patient outcomes across 60 countries worldwide.
Committed to advancing medical technology, B. Braun delivers innovative solutions for infusion therapy, surgical instruments, and dialysis to improve patient outcomes across 60 countries worldwide.
Leadership Roles at B. Braun
Sri Sulistiowati - Chief Financial Officer
Sri Sulistiowati, the Chief Financial Officer at B. Braun, directs all fiscal planning and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures rigorous compliance with international accounting standards while supporting the development of medical devices and pharmaceutical products. This leadership role involves managing complex budgetary frameworks to sustain long-term growth across diverse global markets. By optimizing resource distribution, Sri Sulistiowati directly impacts the company's ability to invest in cutting-edge infusion therapy and surgical instrument research. Ultimately, the Chief Financial Officer secures the economic stability required for the firm to maintain a competitive edge in the multinational healthcare sector, ensuring that every investment aligns with the broader mission of enhancing patient care through superior engineering and manufacturing excellence.
Edwin Omar - Chief Financial Officer & Bbraun Medical Peru S A Board Member
Edwin Omar, the Chief Financial Officer & Bbraun Medical Peru S A Board Member at B. Braun, directs financial governance and strategic planning for regional operations. Overseeing the fiscal performance of the Peruvian division, the Chief Financial Officer & Bbraun Medical Peru S A Board Member ensures alignment with corporate objectives regarding wound care and infusion therapy market expansion. This leadership role involves managing local regulatory requirements and capital investments to strengthen the company's footprint in South America. By monitoring regional revenue streams and cost structures, Edwin Omar directly impacts the profitability of the local subsidiary. Ultimately, the Chief Financial Officer & Bbraun Medical Peru S A Board Member secures the financial viability of regional initiatives, ensuring that the organization maintains a robust presence while delivering high-quality medical solutions to local healthcare systems.
Scott Farrell - Group Chief Financial Officer
Scott Farrell, the Group Chief Financial Officer at B. Braun, directs the overarching financial strategy and global investment portfolio. Overseeing the consolidated fiscal reporting for the entire multinational entity, the Group Chief Financial Officer ensures that capital resources support the development of advanced surgical instruments and pharmaceutical innovations. This leadership role involves coordinating with the board to evaluate long-term market trends and risk management protocols. By analyzing global economic indicators, Scott Farrell directly impacts the company's ability to scale manufacturing operations and enter new territories. Ultimately, the Group Chief Financial Officer secures the financial foundation of the organization, ensuring that the firm remains a leader in the medical device industry through disciplined fiscal management and strategic allocation of assets across all international business units.
Muhammad Arqam - Chief Financial Officer & Head of Strategic Accounts Management
Muhammad Arqam, the Chief Financial Officer & Head of Strategic Accounts Management at B. Braun, directs the intersection of financial planning and high-value client relationships. Overseeing the management of key hospital accounts, the Chief Financial Officer & Head of Strategic Accounts Management ensures that pricing models and service agreements maximize value for both the company and healthcare providers. This leadership role involves negotiating complex contracts for infusion therapy and hospital pharmacy solutions. By aligning financial targets with client-specific needs, Muhammad Arqam directly impacts the retention and growth of the most critical business partnerships. Ultimately, the Chief Financial Officer & Head of Strategic Accounts Management secures sustainable revenue streams, ensuring that the organization maintains strong, mutually beneficial relationships with major healthcare institutions while upholding the highest standards of product quality and service delivery.
Cristian Vacarezza - Principal Chief Financial Officer
Cristian Vacarezza, the Principal Chief Financial Officer at B. Braun, directs the core financial operations and internal audit functions. Overseeing the integrity of financial reporting, the Principal Chief Financial Officer ensures that all manufacturing and marketing activities adhere to strict corporate governance standards. This leadership role involves refining internal processes to improve operational efficiency and cost-effectiveness across the medical device product lines. By implementing advanced financial controls, Cristian Vacarezza directly impacts the accuracy of performance metrics and the transparency of the company's fiscal health. Ultimately, the Principal Chief Financial Officer secures the reliability of financial data, ensuring that the organization can make informed strategic decisions regarding product development and market expansion, thereby maintaining the company's reputation for excellence in the global medical and pharmaceutical sectors.
Yazmin Ruiz - Chief Financial Officer (Mexico)
Yazmin Ruiz, the Chief Financial Officer (Mexico) at B. Braun, directs the financial operations and regional growth strategies within the Mexican market. Overseeing the local budget and resource allocation, the Chief Financial Officer (Mexico) ensures that the company's infusion therapy and surgical instrument offerings remain competitive and accessible to local healthcare providers. This leadership role involves navigating regional economic fluctuations and managing local tax compliance. By optimizing the financial performance of the Mexican subsidiary, Yazmin Ruiz directly impacts the company's ability to serve the growing demand for high-quality medical products in the region. Ultimately, the Chief Financial Officer (Mexico) secures the financial stability of the local operations, ensuring that the organization continues to provide essential medical solutions while achieving sustainable growth in the North American market.
Punrada Lertkomonsuk - Chief Financial Officer, B Braun Ltd (Thailand)
Punrada Lertkomonsuk, the Chief Financial Officer, B Braun Ltd (Thailand) at B. Braun, directs the financial planning and operational accounting for the Thai division. Overseeing the fiscal health of local operations, the Chief Financial Officer, B Braun Ltd (Thailand) ensures that the company's medical devices and pharmaceutical solutions are distributed efficiently across the region. This leadership role involves managing local currency risks and ensuring compliance with regional financial regulations. By streamlining financial processes, Punrada Lertkomonsuk directly impacts the profitability and market penetration of the company's products in Southeast Asia. Ultimately, the Chief Financial Officer, B Braun Ltd (Thailand) secures the financial foundation of the local entity, ensuring that the organization maintains a strong competitive position while delivering high-quality healthcare solutions to patients and medical professionals throughout the region.
Prit Patel - Chief Information Officer
Prit Patel, the Chief Information Officer at B. Braun, architects the digital infrastructure supporting global manufacturing and pharmaceutical distribution. Overseeing enterprise-wide data security and systems integration, the Chief Information Officer drives the digital transformation of hospital pharmacy solutions and dialysis service platforms. This leadership role involves aligning technological capabilities with the operational demands of a multinational medical device manufacturer. By implementing scalable cloud solutions and advanced analytics, Prit Patel directly impacts the efficiency of supply chain logistics and clinical data management. Ultimately, the Chief Information Officer secures the integrity of information systems across 60 countries, ensuring that the company maintains seamless connectivity between research facilities, manufacturing plants, and healthcare providers, thereby facilitating the rapid delivery of critical medical products to patients in need worldwide.
Paul Alderete - Chief Administrative Officer
Paul Alderete, the Chief Administrative Officer at B. Braun, directs the organizational infrastructure and internal support services. Overseeing human resources, facility management, and corporate compliance, the Chief Administrative Officer ensures that the company's global workforce remains aligned with the mission of advancing medical technology. This leadership role involves optimizing administrative workflows to support the manufacturing and marketing of infusion therapy and surgical instruments. By fostering a culture of operational excellence, Paul Alderete directly impacts the productivity and engagement of employees across all international locations. Ultimately, the Chief Administrative Officer secures the operational efficiency of the organization, ensuring that all departments have the necessary resources and support to deliver high-quality medical products and services to healthcare providers and patients worldwide, thereby maintaining the company's status as a leader in the medical device industry.
Mor Vamos - Chief Operations Officer
Mor Vamos, the Chief Operations Officer at B. Braun, directs the global manufacturing and supply chain logistics for all medical devices and pharmaceutical products. Overseeing the production facilities and distribution networks, the Chief Operations Officer ensures that the company maintains the highest standards of quality and safety in infusion therapy, surgical instruments, and wound care solutions. This leadership role involves coordinating with research and development teams to scale new product launches across 60 countries. By optimizing manufacturing processes and logistics, Mor Vamos directly impacts the company's ability to meet the urgent needs of healthcare providers worldwide. Ultimately, the Chief Operations Officer secures the operational reliability of the firm, ensuring that the organization delivers life-saving medical solutions with precision and efficiency, thereby reinforcing the company's commitment to improving patient outcomes through superior manufacturing and operational excellence.
Explore Leadership Teams in Manufacturing
Founded in 1989 and headquartered in Princeton, New Jersey, Integra LifeSciences is a medical technology company that develops and manufactures surgical instruments, neurosurgical devices, and advanced wound care and tissue repair products. Through its Codman Specialty Surgical and Tissue Technologies segments, the company serves neurosurgeons, neurocritical care teams, ENT specialists, plastic and reconstructive surgeons, and general surgeons. Its portfolio includes neurosurgical tools and systems such as dural repair products, cerebrospinal fluid management devices, intracranial monitoring equipment, and cranial stabilization devices, as well as surgical headlamps and general surgical instruments. Integra also provides specialized solutions for acute and chronic wound management, including burns and diabetic foot ulcers, and offers products for soft tissue, bone, nerve, and tendon repair. In ear, nose, and throat care, the company supplies instrumentation, balloon technologies for sinus and eustachian tube dilation, and surgical navigation systems. Sold through direct sales teams and distribution partners to hospitals, surgery centers, and healthcare providers worldwide, Integra LifeSciences positions itself as a comprehensive partner for complex surgical and reconstructive care.
Company Leadership VA
SE
CV
LifeNet Health is a nonprofit organization dedicated to advancing the field of regenerative medicine through innovative transplantation and cellular solutions. The organization provides comprehensive tissue and organ donation services while supporting healthcare providers, researchers, and patients worldwide. By combining cutting-edge medical technology with rigorous quality standards, LifeNet Health enables life-saving procedures and regenerative therapies that enhance patient outcomes and improve quality of life.
Company Leadership RT
JS
PG
PJ
ESTABLISHMENT LABS HOLDINGS INC. (NASDAQ:ESTA) is a global medical technology company dedicated to improving women’s health and wellness through the power of science, engineering, and technology. The Company offers a portfolio of Femtech solutions for breast health, breast aesthetics and breast reconstruction. The Motiva Flora® tissue expander is the only regulatory-approved expander in the world with an integrated port that is MRI conditional and is used to improve outcomes in breast reconstruction following breast cancer. Mia Femtech, Establishment Lab’s unique minimally invasive experience for breast harmony, is the Company’s most recent breakthrough innovation. These solutions are supported by over 200 patent applications in 25 separate patent families worldwide and over 50 scientific studies and publications in peer-reviewed journals.
Company Leadership
Teleflex Incorporated is a global provider of medical technology products founded in 1943 and headquartered in Wayne, Pennsylvania. The company designs, develops, manufactures, and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Teleflex's product portfolio spans vascular access, interventional cardiology and radiology, anesthesia, respiratory care, surgery, and urology, serving healthcare providers across more than 40 countries. The company operates through three geographic segments Americas, EMEA, and Asia Pacific and markets its products under a portfolio of established brands. Teleflex trades on the New York Stock Exchange under the ticker symbol TFX.
Company Leadership
Frequently Asked Questions Regarding B. Braun Top Executives and Leadership Team
